BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21042219)

  • 1. DSM-5 proposals for mood disorders: a cost-benefit analysis.
    First MB
    Curr Opin Psychiatry; 2011 Jan; 24(1):1-9. PubMed ID: 21042219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V.
    Watson D
    J Abnorm Psychol; 2005 Nov; 114(4):522-36. PubMed ID: 16351375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatry. Experts map the terrain of mood disorders.
    Holden C
    Science; 2010 Feb; 327(5969):1068. PubMed ID: 20185697
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of mood disorders in DSM-V and DSM-VI.
    Joyce PR
    Aust N Z J Psychiatry; 2008 Oct; 42(10):851-62. PubMed ID: 18777229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emotional disorders: cluster 4 of the proposed meta-structure for DSM-V and ICD-11.
    Goldberg DP; Krueger RF; Andrews G; Hobbs MJ
    Psychol Med; 2009 Dec; 39(12):2043-59. PubMed ID: 19796429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.
    Alexander JL; Dennerstein L; Kotz K; Richardson G
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S45-58. PubMed ID: 18039068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment.
    Brown TA; Barlow DH
    Psychol Assess; 2009 Sep; 21(3):256-71. PubMed ID: 19719339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the mood and anxiety semi-structured (MASS) interview for patients with intellectual disabilities.
    Charlot L; Deutsch C; Hunt A; Fletcher K; McLlvane W
    J Intellect Disabil Res; 2007 Oct; 51(Pt 10):821-34. PubMed ID: 17803500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional evidence for a quantitative hierarchical model of mood and anxiety disorders for DSM-V: the context of personality structure.
    Tackett JL; Quilty LC; Sellbom M; Rector NA; Bagby RM
    J Abnorm Psychol; 2008 Nov; 117(4):812-25. PubMed ID: 19025228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of posttraumatic stress disorders].
    Lueger-Schuster B
    Psychiatr Danub; 2008 Dec; 20(4):521-31. PubMed ID: 19011594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distress and fear disorders: an alternative empirically based taxonomy of the "mood" and "anxiety" disorders.
    Clark LA; Watson D
    Br J Psychiatry; 2006 Dec; 189():481-3. PubMed ID: 17139030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a U-shaped relationship exist between alcohol use and DSM-III-R mood and anxiety disorders?
    Sareen J; McWilliams L; Cox B; Stein MB
    J Affect Disord; 2004 Oct; 82(1):113-8. PubMed ID: 15465583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of the CBCL/YSR DSM-IV scales Anxiety Problems and Affective Problems.
    Ferdinand RF
    J Anxiety Disord; 2008; 22(1):126-34. PubMed ID: 17321103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of the DSM.
    Borsboom D
    Arch Gen Psychiatry; 2002 Jun; 59(6):569-70; author reply 570-1. PubMed ID: 12044207
    [No Abstract]   [Full Text] [Related]  

  • 16. Co-occurrence of 12-month mood and anxiety disorders and personality disorders in the US: results from the national epidemiologic survey on alcohol and related conditions.
    Grant BF; Hasin DS; Stinson FS; Dawson DA; Patricia Chou S; June Ruan W; Huang B
    J Psychiatr Res; 2005 Jan; 39(1):1-9. PubMed ID: 15504418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews.
    Bragatti JA; Torres CM; Londero RG; Assmann JB; Fontana V; Martin KC; Hidalgo MP; Chaves ML; Bianchin MM
    Epileptic Disord; 2010 Dec; 12(4):283-91. PubMed ID: 21112827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of mental disorders in subjects with intellectual disability in the Lundby cohort 1947-97.
    Nettelbladt P; Göth M; Bogren M; Mattisson C
    Nord J Psychiatry; 2009; 63(4):316-21. PubMed ID: 19229734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
    Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.